QA: Intra Cellular Therapies Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567514_2019_Intra_Cellular_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001567514, Intra Cellular Therapies Inc

  xvar xval
0 AssetsCurrent 355,438,681
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,159,766
3 remainder_Assets 608,051
4 LiabilitiesCurrent 36,299,185
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,192,432
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 39,243,157
9 ResearchAndDevelopmentExpense 126,684,979
10 remainder_Expenses -573,736
11 remainder_Revenues 70,902
12 remainder_NetIncome 6,082,429
13 remainder_ComprehensiveNetIncome -458,961
  yvar yval
0 Assets 357,206,498
1 Liabilities 39,491,617
2 Expenses 165,354,400
3 Revenues 70,902
4 StockholdersEquity 317,714,881
5 NetIncome -159,201,069
6 ComprehensiveNetIncome -159,430,550
7 BaseVar 284,332,404
8 EconomicCapitalRatiobeforeLimitedLiability 2.69
9 EconomicCapitalRatio 3.48

Edgar->Model Mapping

Feature Distribution

Change over Time